Psychiatric Disorders and treatments: A Primer for Teachers

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.

Arnold L. E. , Jensen P. S. , Hechtman L. , Hoagwood K. , Greenhill L. & MTA Cooperative Group. (2000, October). Do MTA treatment effects persist? New follow-up at 2 years. Paper presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry, New York.

Asarnow J. R. , Jaycox L. H. , & Tompson M. C. (2001). Depression in youth: Psychosocial interventions. Journal of Clinical Child Psychology, 30, 33–47.

Beichtman J. H. , Cantwell D. P. , Forness S. R. , Kavale K. A. , & Kauffman J. M. (1998). Practice parameters for the diagnostic assessment and treatment of children and adolescents with language and learning disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 37(10 Supplement), 42S–62S.

Bernstein G. A. , & Shaw K. (1997). Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 36(10 Supplement), 69–84.

Birmaher B. , & Brent D. (1998). Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 37(10 Supplement), 63–83.

Forness S. R. , & Kavale K. A. (2001). Ignoring the odds: Hazards of not adding the medical model to special education decisions. Behavioral Disorders, 26, 269–281.

Forness S. R. , & Kavale K. A. (2002). Impact of ADHD on school systems. In Jensen P. S. , & Cooper J. R. (Eds.), Attention deficit hyperactivity disorder: State of the science best practices, (pp. 1–20, 24). Kingston, NJ: Civic Research Institute.

Forness S. R. , & Kavale K. A. , & Davanzo P. A. (2002). Interdisciplinary treatment and the limits of behaviorism. Behavioral Disorders, 27, 168–178.

Forness S. R. , Kavale K. A. , Sweeney D. P. , & Crenshaw T. M. (1999). The future of research and practice in behavioral disorders: Psychopharmacology and its school treatment implications. Behavioral Disorders, 24, 305–318.

Forness S. R. , Kavale K. A. , & Walker H. M. (1999). Identifying children at risk for antisocial behavior: The case for comorbidity. In Gallimore R. G. , Bernheimer C. , MacMillan D. L. , & Speece D. (Eds.), Developmental perspectives on children with high incidence disabilities (pp. 135–155). Mahwah, NJ: Lawrence Erlbaum.

Gadow K. , & Sprafkin J. (1994). Child Symptom Inventory manual. Stony Brook, NY: Checkmate Plus.

Garland A. F. , Hough R. L. , McCabe K. M. , Yeh M. , Wood P. A. , & Aarons G. A. (2001). Prevalence of psychiatric disorders in youths across five sectors of care. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 409–418.

Green W. H. (2001). Child and adolescent clinical psychopharmacology (3rd ed.). New York: Guilford Press.

Jensen P. S. , Hinshaw S. P. , Kraemer H. C. , Lenora N. , Newcorn J. H. , Abikoff H. B. , March J. S. , Arnold L. E. , Cantwell D. P. , Conner C. K. , Elliott G. R. , Greenhill L. L. , Hechtman L. , Hoaz B. , Pelham W. E. , Severe J. B. , Swanson J. M. , Wells K. C. , Wigal T. , & Vitiello B. (2001). ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 147–158.

Jensen P. S. , Kettle L. , Roper M. T. , Sloan M. T. , Dulcan M. K. , Hoven C. , Bird H. R. , Bauermeister J. J. , & Payne J. D. (1999). Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 797–804.

Kavale K. A. , Forness S. R. , & Walker H. M. (1999). Interventions for ODD and CD in the schools. In Quay H. , & Hogan A. (Eds.), Handbook of disruptive behavior disorders (pp. 441–454). New York: Plenum.

King B. H. , DeAntonio C. , McCracken J. T. , Forness S. R. , & Ackerman V. (1994). Psychiatric consultation to persons with severe and profound mental retardation. American Journal of Psychiatry, 151, 1802–1808.

Konopasek D. E. (2002). Medication “Fact Sheets”: A medication reference guide for the non-medical professional. Anchorage, AK: Arctic Tern.

Lewis M. (Ed.). (2002). Child and adolescent psychiatry: A comprehensive textbook (3rd ed.). New York: Guilford Press.

McClellan J. , & Werry J. (2000). Summary of the practice parameters for the assessment and treatment of children and adolescents with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 1580–1582.

MTA Cooperative Group, (1999a). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073–1086.

MTA Cooperative Group. (1999b). Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1088–1095.

Ollendick T. , & King N. (1998). Empirically supported treatments for children with phobic and anxiety disorders: Current status. Journal of Clinical Child Psychology, 27, 156–167.

Swanson J. M. , Kraemer H. C. , Hinshaw S. P. , Arnold L. E. , Conners C. K. , Abikoff H.B. , Clevenger W. , Davies M. , Elliot G. R. , Greenhill L. L. , Hechtman L. , Hoza B. , Jensen P. S. , March J. S. , Newcorn J. H. , Owns E. B. , Pelham W. , Schiller E. , Severe J. B. , Simpson S. , Vitiello B. , Wells K. , Wigal T. , & Wu M. (2001). Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 168–179.

Sweeney D. P. , Forness S. R. , & Levitt J. G. (1998). An overview of medications commonly used to treat behavioral disorders associated with autism, Tourette's disorder, and pervasive developmental disorders. Focus on Autism and Other Developmental Disabilities, 13, 144–150.

Vitiello B. , Bhatara V. S. , & Jensen P. S. (1999). Special section: Current knowledge and unmet needs in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 501–565.

Volkmar F. , Cook E. H. , Pomeroy J. , Realmuto G. , & Tanguay P. (1999). Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 38(12 Supplement), 32–54.

Wagner K. D. , & Ambrosini P. J. (2001). Childhood depression: Pharmacological therapy/treatment (Pharmacotherapy of childhood depression). Journal of Clinical Child Psychology, 30, 88–97.

Wilens T. E. (2001). Straight talk about psychiatric medication for kids. New York: Guilford Press.

Zito J. M. , Safer D. J. , Riddle M. A. , Johnson R. E. , Speedie S. M. , & Fox M. (1998). Prevalence variations in psychotropic treatment of children. Journal of Child and Adolescent Psychopharmacology, 8, 99–105.